Zacks Investment ResearchFri, 08 May 2026 18:30:28 GMTTBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline HurdleTBPH+1.22%
Zacks Investment ResearchThu, 07 May 2026 14:50:20 GMTHere's Why Theravance Biopharma (TBPH) is a Strong Momentum StockTBPH+1.22%
Zacks Investment ResearchThu, 16 Apr 2026 18:15:35 GMTTheravance Stock Declines Around 17% in Three Months: Here's WhyTBPH+1.22%
Zacks Investment ResearchWed, 15 Apr 2026 14:50:24 GMTHere's Why Theravance Biopharma (TBPH) is a Strong Momentum StockTBPH+1.22%
